Norepinephrine Transporter Imaging in Addiction Disorders
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
In this study we propose to study 24 unmedicated abstinent alcohol dependent patients, 24
obese individuals and 24 individually matched healthy control subjects and determine
Norepinephrine Transporter (NET) expression in vivo using (S,S)-[11C]MRB and PET.
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)